Evaluation of a new method of measuring anti-cyclic citrullinated peptides antibodies by fluorometry for the diagnosis of rheumatoid arthritis;Évaluation d'une nouvelle méthode de dosage par fluorométrie des autoanticorps anti-peptides cycliques citrullinés pour le diagnostic de polyarthrite rhumatoïde

Annales de Biologie Clinique

Volumn 64, Issue 2, 2006, Pages 162-165

  Dubois Galopin, F ^a   Masson, C ^a   Chevallier, A ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Anti cyclic citrullinated peptides antibodies; Fluorometric immunoassay; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; FLUOROMETRY; HUMAN; IMMUNOASSAY; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; FLUOROMETRY; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; REPRODUCIBILITY OF RESULTS;

EID: 33749074246     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Goldblatt F, Isenberg DA. New therapies for rheumatoid arthritis. Clin Exp Immunol 2005; 140: 195-204.
2. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4: 87-93.
3. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
4. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003; 25: 1106-18.
5. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatol 2002; 41: 809-14.
6. Sebbag M, Chapuy-Regaud S, Auger I, et al. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Joint Bone Spine 2004; 71: 493-502.
7. Vassault A, Grafmeyer D, Naudin CI, et al. Protocole de validation de techniques. Ann Biol Clin (Paris) 1986; 44: 686-745.
8. Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003; 62: 427-30.
9. Renier G, Chevallier A. Quelques pièges diagnostiques en immunologie. Rev Fr Lab 2005; 371: 33-40.